5.42
price up icon0.18%   0.010
after-market 시간 외 거래: 5.42
loading

Third Harmonic Bio Inc 주식(THRD)의 최신 뉴스

pulisher
Jun 16, 2025

Layoff Tracker: Gilead Cuts 36 Employees in California - BioSpace

Jun 16, 2025
pulisher
Jun 13, 2025

AstraZeneca forms an AI deal in China; Third Harmonic advances liquidation plans - BioPharma Dive

Jun 13, 2025
pulisher
Jun 13, 2025

Third Harmonic Bio stockholders approve liquidation plan, set distribution By Investing.com - Investing.com India

Jun 13, 2025
pulisher
Jun 12, 2025

Finance Watch: Insmed Cashes In On Positive Data With $750m Offering - insights.citeline.com

Jun 12, 2025
pulisher
Jun 12, 2025

THRD Stockholders Approve Liquidation Plan with Initial Payouts Expected | THRD Stock News - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Third Harmonic Bio receives stockholder approval of plan of liquidation - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

Third Harmonic Bio reports updated THB335 data, initiates THB335 sale - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

ADC Therapeutics reveals layoffs, $100M PIPE; Third Harmonic seeks buyer for asset - Endpoints News

Jun 12, 2025
pulisher
Jun 12, 2025

Third Harmonic Bio To Dissolve; THB335 Shows Promise, Sale Process Now Underway - Nasdaq

Jun 12, 2025
pulisher
Jun 12, 2025

Third Harmonic Bio stockholders approve liquidation plan, set distribution - Investing.com

Jun 12, 2025
pulisher
Jun 12, 2025

Third Harmonic Bio Approves Liquidation and Dissolution Plan - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

THRD Advances THB335 to Phase 2 Trials with Positive Phase 1 Results | THRD Stock News - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Third Harmonic Bio Announces Stockholder Approval of Plan of Liquidation and Dissolution, Updated THB335 Phase 1 Clinical Data, and Initiation of Sale of THB335 - The Manila Times

Jun 12, 2025
pulisher
Jun 12, 2025

Third Harmonic Bio Shareholders Win Big: $5.35/Share Payout Approved as Drug Shows 85% Efficacy - Stock Titan

Jun 12, 2025
pulisher
Jun 11, 2025

Third Harmonic Bio Approves Key Proposals at Annual Meeting - TipRanks

Jun 11, 2025
pulisher
Jun 06, 2025

At a crossroads, biotechs are passing on reverse mergers in 2025 - Endpoints News

Jun 06, 2025
pulisher
Jun 05, 2025

Fierce Biotech Layoff Tracker 2025: Rapt reduces workforce; Plexium pares down staff - Fierce Biotech

Jun 05, 2025
pulisher
May 30, 2025

Third Harmonic Bio Reports Q1 2025 Financial Results - TipRanks

May 30, 2025
pulisher
May 28, 2025

Cancer drugmaker iTeos to shut down - BioPharma Dive

May 28, 2025
pulisher
May 16, 2025

It’s been three months without a biotech IPO - Endpoints News

May 16, 2025
pulisher
May 08, 2025

THIRD HARMONIC BIO Earnings Results: $THRD Reports Quarterly Earnings - Nasdaq

May 08, 2025
pulisher
May 08, 2025

Third Harmonic Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 08, 2025
pulisher
May 05, 2025

Third Harmonic Bio Announces Plan of Liquidation and Dissolution - ADVFN

May 05, 2025
pulisher
May 02, 2025

Here’s Why Third Harmonic Bio (THRD) Fell in Q1 - Insider Monkey

May 02, 2025
pulisher
Apr 29, 2025

Acelyrin should liquidate instead of merging with Alumis, investor says - BioPharma Dive

Apr 29, 2025
pulisher
Apr 27, 2025

Third Harmonic Bio’s CSO Christopher Dinsmore Steps Down - MSN

Apr 27, 2025
pulisher
Apr 23, 2025

Third Harmonic Bio CSO steps down, enters separation agreement - Investing.com Australia

Apr 23, 2025
pulisher
Apr 23, 2025

Third Harmonic Bio Plans Liquidation With Lucrative Payouts - Finimize

Apr 23, 2025
pulisher
Apr 22, 2025

Third Harmonic Bio CSO steps down, enters separation agreement By Investing.com - Investing.com South Africa

Apr 22, 2025
pulisher
Apr 21, 2025

Dupixent bounces back in treating hives with FDA approval - BioWorld MedTech

Apr 21, 2025
pulisher
Apr 18, 2025

New fund Alis offers struggling biotechs an off-ramp: Finance Report - BioCentury

Apr 18, 2025
pulisher
Apr 17, 2025

Finance Watch: Investors Push ESSA Pharma, Elevation Oncology To Wind Down - insights.citeline.com

Apr 17, 2025
pulisher
Apr 16, 2025

SF biotech company, once worth nearly $1 billion, plans to shut down - SFGATE

Apr 16, 2025
pulisher
Apr 16, 2025

Biotech Alert: Searches spiking for these stocks today - TipRanks

Apr 16, 2025
pulisher
Apr 16, 2025

Third Harmonic Bio (THRD) Plans Liquidation; Significant Search Surge in Biotech Sector | ARTL Stock News - GuruFocus

Apr 16, 2025
pulisher
Apr 15, 2025

Third Harmonic Bio (THRD) Seeks Stockholder Approval for Liquida - GuruFocus

Apr 15, 2025
pulisher
Apr 15, 2025

Third Harmonic Bio plans to liquidate the company, sell urticaria treatment - MSN

Apr 15, 2025
pulisher
Apr 15, 2025

Third Harmonic Bio, Inc. Liquidation and Shareholder Distribution: Analyst Maintains Hold Rating Amid Strategic Uncertainties - TipRanks

Apr 15, 2025
pulisher
Apr 15, 2025

Third Harmonic's shutdown, Coherus and Xoma drug sales connectedBizwomen - The Business Journals

Apr 15, 2025
pulisher
Apr 15, 2025

Third Harmonic Bio leaps as it reveals liquidation plan - The Pharma Letter

Apr 15, 2025
pulisher
Apr 15, 2025

Big moves by small biotechs signal potential shift for investorsSan Francisco Business Times - The Business Journals

Apr 15, 2025
pulisher
Apr 15, 2025

Top 3 Health Care Stocks You May Want To Dump This Quarter - Benzinga

Apr 15, 2025
pulisher
Apr 15, 2025

Third Harmonic Bio Announces Liquidation Plan: Stock Skyrockets 39% Pre-Market, But Retail’s Shattered - MSN

Apr 15, 2025
pulisher
Apr 14, 2025

$26bn Brighton Jones hires new CFO - Citywire

Apr 14, 2025
pulisher
Apr 14, 2025

Third Harmonic Bio plans liquidation and asset sale By Investing.com - Investing.com South Africa

Apr 14, 2025
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
자본화:     |  볼륨(24시간):